{
  "id": 8069824,
  "title": "NewSpring Capital leads financing for cell therapy CDMO merger Kincellis",
  "url": "https://urgent.news/2026/09/17/newspring-capital-leads-financing-for-cell-therapy-cdmo-merger",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-17T17:23:05.000Z",
  "source": {
    "name": "PE Hub",
    "slug": "pe-hub",
    "url": "https://www.pehub.com/newspring-capital-leads-financing-for-cell-therapy-cdmo-merger-kincellis/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Kincellis Advanced Therapies is a US-based contract development and manufacturing organization for cell and advanced-therapy modalities, operating roughly 140,000 square feet of GMP manufacturing space across Florida, North Carolina and Texas. The post NewSpring Capital leads financing for cell therapy CDMO merger Kincellis appeared first on PE Hub .",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}